THE INVESTOR

메뉴열기
March 28, 2024

SK Biopharm seeks USFDA’s approval for new drug candidate

PUBLISHED : November 26, 2018 - 12:47

UPDATED : November 26, 2018 - 12:47

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • sms

[DISCLOSURE] SK (034730) announced on Nov. 26 that its subsidiary SK Biopharm has handed in new drug application for US Food and Drug Administration’s approval for its novel epilepsy drug candidate Cenobamate.  

By Hwang You-mee (glamazon@heraldcorp.com)

  • 페이스북
  • sms
최상단으로
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.